BLATTA ORIENTALIS
BLATTA ORIENTALIS is an FDA drug label for the active ingredient BLATTA ORIENTALIS manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231208.
Generic: BLATTA ORIENTALIS
Manufacturer: Boiron
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 0220-0865
Application:
Effective: 20231208
Active Ingredients: Blatta orientalis 200CK Active ingredient**: See product name on front panel (**contains 0.443 mg of the active ingredient per pellet).
Indications & Usage
Relieves respiratory allergies * See symptoms on front panel.
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.
More from same ingredient
Blatta Orientalis
Hahnemann Laboratories, INC.
Blatta orientalis
Boiron
Blatta orientalis
Boiron
Blatta orientalis
Boiron
Blatta orientalis
Boiron
Blatta orientalis
Boiron